GEODE CAPITAL MANAGEMENT, LLC
Position in UNCY — Unicycive Therapeutics, Inc.
CIK 1214717
BOSTON, MA
Position in UNCY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,645,248
+$1,304,613 QoQ
Shares Held
564,019
+176.8% QoQ
Ownership
2.02%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 80 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UNCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. UNCY ranks #283 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in UNCY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,645,248 | 564,019 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,340,635 | 203,744 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $988,342 | 171,290 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $548,168 | 125,727 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $280,409 | 58,786 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $333,041 | 579,202 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $416,442 | 524,487 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $164,177 | 402,398 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $143,154 | 285,738 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $349,406 | 253,193 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $146,806 | 169,132 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $45,063 | 52,399 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $85,442 | 66,752 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $201,385 | 95,898 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $14,098 | 26,109 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $15,404 | 26,109 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $21,670 | 26,109 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $33,680 | 26,109 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $53,784 | 26,109 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $73,888 | 26,109 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||